Black Diamond Therapeutics BDTX

$ 2.23 1.83%

Quarterly report 2024-Q3
added 11-05-2024

Black Diamond Therapeutics Balance Sheet 2011-2024 | BDTX

Annual Balance Sheet Black Diamond Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-30.9 M	-6.18 M	-37.3 M	-19.2 M	-155 M	-51.7 M	-7.88 M	-	-	-	-	-	-
Long Term Debt	22.2 M	25.3 M	28.1 M	7.69 M	-	-	-	-	-	-	-	-	-
Long Term Debt Current	3.11 M	2.84 M	320 K	1.05 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	7.69 M	201 M	64.8 M	12.5 M	-	-	-	-	-	-
Total Current Liabilities	19.6 M	15.3 M	23.6 M	14.2 M	4.86 M	-	-	-	-	-	-	-	-
Total Liabilities	41.8 M	40.6 M	51.8 M	21.9 M	205 M	67.4 M	14.7 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-417 M	-335 M	-244 M	-118 M	-51 M	-15.7 M	-6.78 M	-	-	-	-	-	-
Total Assets	159 M	156 M	248 M	330 M	158 M	51.8 M	8.02 M	-	-	-	-	-	-
Cash and Cash Equivalents	56.2 M	34.3 M	65.8 M	34.6 M	155 M	51.7 M	-	-	-	-	-	-	-
Book Value	117 M	116 M	196 M	308 M	-47.2 M	-15.5 M	-6.68 M	-	-	-	-	-	-
Total Shareholders Equity	117 M	116 M	196 M	308 M	-47.2 M	-15.5 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Black Diamond Therapeutics

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	19.7 M	20.5 M	22.2 M	23 M	23.8 M	24.5 M	25.3 M	26 M	26.8 M	27.5 M	28.1 M	28.8 M	13.4 M	13.8 M	7.69 M	7.69 M	7.69 M	7.69 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	40.5 M	39 M	41.8 M	38.1 M	37.7 M	37.4 M	40.6 M	47.2 M	46.5 M	46.9 M	51.8 M	55.2 M	36.9 M	32.5 M	21.9 M	21.9 M	21.9 M	21.9 M	4.88 M	4.88 M	4.88 M	4.88 M	6.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-471 M	-456 M	-417 M	-398 M	-375 M	-356 M	-335 M	-314 M	-292 M	-269 M	-244 M	-218 M	-183 M	-149 M	-118 M	-118 M	-118 M	-118 M	-51 M	-51 M	-51 M	-51 M	-15.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	138 M	150 M	159 M	172 M	120 M	136 M	156 M	180 M	199 M	219 M	248 M	274 M	288 M	313 M	330 M	330 M	330 M	330 M	158 M	158 M	158 M	158 M	51.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	23.4 M	32.8 M	56.2 M	58 M	41.9 M	39.1 M	34.3 M	54 M	55.9 M	54.1 M	65.8 M	46.6 M	37.3 M	14.1 M	35.8 M	34.6 M	34.6 M	34.6 M	155 M	155 M	155 M	155 M	51.7 M	-	-	-	7.88 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	97.4 M	111 M	117 M	134 M	82.2 M	98.2 M	116 M	133 M	152 M	173 M	196 M	219 M	251 M	281 M	308 M	308 M	308 M	308 M	153 M	153 M	153 M	153 M	45.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	97.4 M	111 M	117 M	134 M	82.2 M	98.2 M	116 M	133 M	152 M	173 M	196 M	219 M	251 M	281 M	308 M	308 M	308 M	308 M	-47.2 M	-47.2 M	-47.2 M	-47.2 M	-15.5 M	-	-	-	-6.68 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency